Tokyo, May 14 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061557) titled 'Nationwide survey on hemophagocytic syndrome as an immune-related adverse event in the treatment of malignant thoracic tumors' on May 13.
Study Type:
Observational
Primary Sponsor:
Institute - Nihon University
Condition:
Condition - Malignant thoracic tumor
Classification by malignancy - Malignancy
Genomic information - NO
Objective:
Narrative objectives1 - To clarify the clinical characteristics of cases of hemophagocytic syndrome caused by immune checkpoint inhibitors in patients with malignant thoracic tumors.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 18
years-old
= 265 mg/dL or Fibrinogen = 50...